Skip to content

Ability of Haemocoagulase- medicine to stop bleeding in children undergoing removal of milk teeth

Effectiveness of topical Haemocoagulase as a haemostatic agent in children undergoing extraction of deciduous teeth â a Split-mouth, Randomized, Double-blind, Clinical Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009784
Enrollment
30
Registered
2017-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1. Healthy children 2. Age group of 5-9 3. Reporting with Parents/Guardians 4. Requiring dental extraction of bilateral deciduous molars of either maxillary or mandibular arch

Interventions

Intervention1: Haemocoagulase (BotroClot Topical Solution): Juggat Pharma Marketing Office #782, 15th Cross, 1st Phase JP Nagar, Bangalore - 560 078 INDIA Ph: 80-26635642, 26635653 Fax: 80-26635271,

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA-I status (Healthy patients) 2. Reporting to OPD 3. Requiring dental extractions of any Bilateral deciduous molars of either maxillary or mandibular arch

Exclusion criteria

Exclusion criteria: 1. Conditions contraindicating Haemocoagulase such as Disseminated Intravascular Coagulation or Afibrinogenemia 2. NSAID-use in previous 24 hours

Design outcomes

Primary

MeasureTime frame
Time taken for Complete cessation of bleedingTimepoint: Time taken for Complete cessation of bleeding

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDinesh Francis Swamy

Goa Dental College and Hospital

dfswamy@gmail.com9483645909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026